XETRA:AJ91
DocCheck AG · XETRA · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 12:22 UTC
Last close
n/aEUR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
9.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
15.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
9.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
4.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.10Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
What it pays out is the furthest below its sector's middle: 0.20 against 0.54 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.14x
Its own average over 10 years, 48.7M.
- Profit1.06x
Its own average over 10 years, 5.0M.
- Free cash flow0.70x
Its own average over 10 years, 3.7M.
- Debt1.25x
Its own average over 10 years, 3.3M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 0.70 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 108.3 | 90.5 | 100.3 |
| 2018-12-31 | 109.3 | 85.4 | 100.3 |
| 2019-12-31 | 124.6 | 117.8 | 100.2 |
| 2020-12-31 | 243.3 | 345.4 | 100.8 |
| 2021-12-31 | 331.3 | 428.0 | 101.2 |
| 2022-12-31 | 234.8 | 236.1 | 101.0 |
| 2023-12-31 | 205.9 | 85.2 | 101.2 |
| 2024-12-31 | 207.4 | 198.3 | 101.3 |
| 2025-12-31 | 213.3 | 200.2 | 101.3 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Figures behind the shape
Growth
-2.6%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate-2.6%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Five-year EPS growth rate-10.5%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
One-year change in net income1.0%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Returns on capital
15.5%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital15.5%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity12.8%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets9.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
22.2%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin22.2%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin13.8%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin9.6%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin4.7%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
9.8xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings9.8x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
Price to book1.3x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA4.0x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.9x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.10safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.10
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio3.18
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage18.5x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score4.83
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
71.3%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Payout ratio71.3%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio0.7x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.